Advancement in drug therapies may provide new treatment for Cutaneous leishmaniasis

Cutaneous leishmaniasis (CL) is a parasitic infection caused by Leishmania parasite. CL cases have increased dramatically in Syria and neighboring countries due to conflict-related displacement of Syrians.